SIRT1-mediated FABP4 destabilization attenuates fibrosis and ferroptosis in non-alcoholic fatty liver disease

Key Points

• FABP4 destabilization significantly reduces fibrosis in liver tissue, improving overall liver health.
• Inhibition of ferroptosis leads to decreased cell death, which may prevent disease progression.
• The analysis focuses on biochemical pathways involved in non-alcoholic fatty liver disease.
• Findings suggest a new approach for treatment, indicating the role of SIRT1 as a therapeutic target.